New York – October 01, 2026 -- Kyndryl (NYSE: KD) found that 98% of organizations that delayed technology modernization experienced negative business impacts, according to the company's first global Modernization Report released today. The study, based on responses from 2,000 business and technology leaders across five continents and 12 industries, shows nearly half of organizations are behind schedule on modernization goals even as AI adoption becomes the dominant investment driver.

Armonk, N.Y. – October 01, 2026 -- IBM has launched a self-hosted deployment option for Bob, its agentic software development platform, allowing enterprises to run AI-powered coding and modernization tools entirely within on-premises, private-cloud, sovereign-cloud, or air-gapped infrastructure.

Tokyo – September 30, 2026 -- TIER IV, the developer behind the open-source autonomous driving software Autoware, has joined Arm Total Design for Physical AI, a move aimed at expanding Autoware's availability across Arm-based system-on-chips and in-vehicle computing platforms.

Alpharetta, Ga. – September 30, 2026 -- Mynd.ai, Inc. (NYSE American: MYND) said its subsidiary Promethean has launched an AI Companion for its Explain Everything app, using on-device artificial intelligence through Apple Intelligence to let educators convert classroom content into teaching materials within seconds.

Las Vegas – September 30, 2026 -- bolttech and Bold Penguin have entered a global strategic partnership to build a combined commercial and personal lines insurance distribution offering spanning the U.S., Europe and Asia.

Los Angeles – September 30, 2026 -- CometAPI now routes access to more than 500 AI models through a single OpenAI-compatible API key, serving over 10,000 active developers with average response times under 400 milliseconds and a 99.9% uptime target.

Indianapolis – – September 30, 2026 -- Eli Lilly and Company (NYSE: LLY) reported that its oral GLP-1 therapy Foundayo (orforglipron) reduced cardiovascular death risk by 53% and all-cause death risk by 57% compared with insulin glargine in the Phase 3 ACHIEVE-4 trial, the largest and longest study of the medicine in type 2 diabetes to date.

Tinton Falls, N.J. – September 30, 2026 -- Commvault (NASDAQ: CVLT) has achieved the AWS Data Competency in the Relational Database category, a designation confirming its technical proficiency in delivering cyber-resilient data protection for relational database workloads on Amazon Web Services.

San Diego – September 30, 2026 -- Halozyme Therapeutics (Nasdaq: HALO) has appointed James "Jim" Daly to its Board of Directors, returning a veteran biopharmaceutical commercial executive to help steer the company's drug-delivery technology expansion.

Sunnyvale – September 30, 2026 -- Synopsys projects fiscal 2027 revenue of $11.15 billion at the midpoint of guidance, a roughly 15% year-over-year increase, the company told investors at its 2026 Investor Day in New York.

The chip-design software maker also plans to repurchase approximately $1 billion of its own shares over the coming months, part of a broader commitment to return up to 50% of free cash flow to shareholders after reinvesting in the business.